🔴 First Tracks Biotherapeutics is trading 10.77% down today as broad market losses pressured growth assets

First Tracks Biotherapeutics is trading 10.77% lower at $36.61 as a broad September 23, 2026 market sell-off weighed on growth-oriented assets.

• The Nasdaq Composite fell 1.05%, while biotechnology stocks declined 2.04%.
• Rising crude oil prices and Treasury yields heightened concerns about inflation and borrowing costs; no fresh company-specific announcement or catalyst was identified.